dihydroergotamine mesylate

(redirected from D.H.E. 45)

dihydroergotamine mesylate

[dīhī′drō·ərgot′əmēn me′si lāt]
an ergot alkaloid causing vasoconstriction through stimulation of several types of receptors, including alpha-adrenergic receptors and serotonin receptors.
indications It is prescribed for the treatment of migraine and vascular headache.
contraindications Cardiovascular disease, hypertension, liver or kidney dysfunction, sepsis, pregnancy, or known hypersensitivity to this drug prohibits its use.
adverse effects Among the more serious adverse reactions are gangrene and the toxicity of the ergot alkaloids.

Migranal

A nasal spray formulation of an ergot compound used to manage migraines, but not hemiplegic or basilar migraines and not as prophylaxis.
 
Adverse effects
Rarely: cardiac events, including coronary artery vasospasm, transient myocardial ischaemia or infarction, ventricular tachycardia and ventricular fibrillation. More commonly: burning sensation, dysgeusia, diarrhoea, dizziness, drowsiness, dry mouth, hot flushes, irritation, nasal congestion or dryness, nasal discharge, nausea, sinusitis, sore throat, exhaustion, weakness.

dihydroergotamine mesylate

(dī-hī″drō-ĕr-gŏt′ă-mēn)
A vasoconstrictor used in treating migraine.
Mentioned in ?
References in periodicals archive ?
Royalty rates on the combined annual net sales of MT 300 and D.
In addition, we created an innovative agreement, where we will receive royalties on the combined sales of MT 300 and D.
People should not take the following medicines with NORVIR because they can cause serious or life-threatening problems such as irregular heartbeat, breathing difficulties or excessive sleepiness: Cordarone (amiodarone); ergotamine, ergonovine, methylergonovine, and dihydroergotamine such as Cafergot, Migranal, D.